Table 4 Power calculation parameters and derivation of control arm outcome estimates at the end of the trial
Characteristics | CV | ICC | 2013 | 2015 | 2013 to 2015 ∆ | Proposed control arm outcome |
|---|---|---|---|---|---|---|
Population viremia prevalence (PVP) | 0.33 | 0.02 | 25% | 16% | 9% | 11.2% |
HIV care coverage | 0.141 | 0.061 | 70% | 75% | 4.8% | 80.1% |
ART coverage | 0.187 | 0.072 | 43% | 67% | 24.6% | 79.7% |
MC coverage | 0.209 | 0.062 | 52% | 59% | 8.1% | 66.9% |
HIV incidence | 0.929 | NA | 3.34 | 2.9 | 0.44 | 2.7 |